Effectiveness of the Influenza Vaccine in Preventing Hospitalizations of Patients with Influenza Community-Acquired Pneumonia

T. Chandler, S. Furmanek, Connor English, Connor Glick, Wesley Trail, Lara Daniels, U. Owolabi, R. Carrico, J. Ramirez, T. Wiemken
{"title":"Effectiveness of the Influenza Vaccine in Preventing Hospitalizations of Patients\n with Influenza Community-Acquired Pneumonia","authors":"T. Chandler, S. Furmanek, Connor English, Connor Glick, Wesley Trail, Lara Daniels, U. Owolabi, R. Carrico, J. Ramirez, T. Wiemken","doi":"10.18297/JRI/VOL2/ISS1/6","DOIUrl":null,"url":null,"abstract":"Introduction: Influenza vaccination is the primary strategy for prevention of influenza infection. Influenza infection can vary from mild or even asymptomatic illness to severe community-acquired pneumonia (CAP). Although many national and international investigators and organizations report annual estimates of influenza vaccine effectiveness for prevention of influenza infection in the community, few studies report estimates for the prevention of hospitalizations due to influenza CAP, the most severe form of the infection. The objective of this study is to determine the effectiveness of the influenza vaccine for prevention of hospitalization in patients with influenza-associated CAP. Methods: This was a test-negative study using data from the first two years of the University of Louisville Pneumonia Study, a prospective, observational study of all hospitalized patients with pneumonia in Louisville, Kentucky from 6/1/2014 – 5/31/2016. Univariate and multivariate logistic models were used to evaluate the association between vaccine status and influenza-associated/noninfluenza-associated CAP hospitalization. Unadjusted and adjusted vaccine effectiveness estimates were calculated. Results: A total of 1951 hospitalized patients with CAP were included in the analysis, and 831 (43%) reported having received the influenza vaccination for the influenza season by the time they were hospitalized. A total of 152 (8%) cases of influenza-CAP were confirmed in the study population, with 63 (8%) cases confirmed in vaccinated individuals. The unadjusted vaccine effectiveness was not significant, with a point estimate of 5% (95% CI: -33%, 32%). After adjusting for potential cofounders, vaccine effectiveness was also found to not be significant with a point estimate of 8% (95% CI: -30%, 35%). Conclusions: In conclusion, we found that, over the 2014/2015 and 2015/2016 influenza seasons, influenza vaccine was not effective for prevention of hospitalization with CAP due to influenza. More effective vaccines are necessary to prevent the most serious forms of influenza. DOI: 10.18297/jri/vol2/iss1/6 Received Date: February 12, 2018 Accepted Date: February 27, 2018 Website: https://ir.library.louisville.edu/jri Affiliations: 1University of Louisville Division of Infectious Diseases, Louisville, KY 40202 2University of Louisville School of Public Health and Information Sciences Department of Epidemiology and Population Health, Louisville, KY 40202 ©2018, The Author(s). *Correspondence To: Thomas R Chandler Work: Address: Division of Infectious Diseases, University of Louisville Work Email: thomas.chandler@louisville.edu 26 ULJRI Vol 2, (1) 2018 ORIGINAL RESEARCH The objective of this study is to determine the effectiveness of the influenza vaccine for prevention of hospitalization in patients with influenza-CAP and to determine how well the estimated effectiveness in the general population estimates the effectiveness in hospitalized patients with CAP.","PeriodicalId":91979,"journal":{"name":"The University of Louisville journal of respiratory infections","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The University of Louisville journal of respiratory infections","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18297/JRI/VOL2/ISS1/6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Influenza vaccination is the primary strategy for prevention of influenza infection. Influenza infection can vary from mild or even asymptomatic illness to severe community-acquired pneumonia (CAP). Although many national and international investigators and organizations report annual estimates of influenza vaccine effectiveness for prevention of influenza infection in the community, few studies report estimates for the prevention of hospitalizations due to influenza CAP, the most severe form of the infection. The objective of this study is to determine the effectiveness of the influenza vaccine for prevention of hospitalization in patients with influenza-associated CAP. Methods: This was a test-negative study using data from the first two years of the University of Louisville Pneumonia Study, a prospective, observational study of all hospitalized patients with pneumonia in Louisville, Kentucky from 6/1/2014 – 5/31/2016. Univariate and multivariate logistic models were used to evaluate the association between vaccine status and influenza-associated/noninfluenza-associated CAP hospitalization. Unadjusted and adjusted vaccine effectiveness estimates were calculated. Results: A total of 1951 hospitalized patients with CAP were included in the analysis, and 831 (43%) reported having received the influenza vaccination for the influenza season by the time they were hospitalized. A total of 152 (8%) cases of influenza-CAP were confirmed in the study population, with 63 (8%) cases confirmed in vaccinated individuals. The unadjusted vaccine effectiveness was not significant, with a point estimate of 5% (95% CI: -33%, 32%). After adjusting for potential cofounders, vaccine effectiveness was also found to not be significant with a point estimate of 8% (95% CI: -30%, 35%). Conclusions: In conclusion, we found that, over the 2014/2015 and 2015/2016 influenza seasons, influenza vaccine was not effective for prevention of hospitalization with CAP due to influenza. More effective vaccines are necessary to prevent the most serious forms of influenza. DOI: 10.18297/jri/vol2/iss1/6 Received Date: February 12, 2018 Accepted Date: February 27, 2018 Website: https://ir.library.louisville.edu/jri Affiliations: 1University of Louisville Division of Infectious Diseases, Louisville, KY 40202 2University of Louisville School of Public Health and Information Sciences Department of Epidemiology and Population Health, Louisville, KY 40202 ©2018, The Author(s). *Correspondence To: Thomas R Chandler Work: Address: Division of Infectious Diseases, University of Louisville Work Email: thomas.chandler@louisville.edu 26 ULJRI Vol 2, (1) 2018 ORIGINAL RESEARCH The objective of this study is to determine the effectiveness of the influenza vaccine for prevention of hospitalization in patients with influenza-CAP and to determine how well the estimated effectiveness in the general population estimates the effectiveness in hospitalized patients with CAP.
流感疫苗预防流行性感冒社区获得性肺炎患者住院的效果
流感疫苗接种是预防流感感染的主要策略。流感感染可以从轻微甚至无症状的疾病到严重的社区获得性肺炎(CAP)。尽管许多国家和国际调查人员和组织每年报告流感疫苗预防社区流感感染有效性的估计,但很少有研究报告因流感CAP(最严重的感染形式)而预防住院的估计。本研究的目的是确定流感疫苗预防流感相关CAP患者住院的有效性。方法:这是一项检测阴性的研究,使用路易斯维尔大学肺炎研究前两年的数据,这是一项前瞻性观察性研究,研究对象是2014年6月1日至2016年5月31日在肯塔基州路易斯维尔所有住院的肺炎患者。单变量和多变量logistic模型用于评估疫苗状况与流感相关/非流感相关CAP住院之间的关系。计算未调整和调整后的疫苗有效性估计值。结果:共有1951例CAP住院患者被纳入分析,其中831例(43%)报告在住院时已接种流感疫苗。在研究人群中共确诊152例(8%)流感- cap病例,其中63例(8%)在接种疫苗的个体中确诊。未调整的疫苗有效性不显著,点估计为5% (95% CI: -33%, 32%)。在对潜在联合创始人进行调整后,疫苗有效性也不显著,点估计值为8% (95% CI: -30%, 35%)。结论:综上所述,我们发现在2014/2015年和2015/2016年流感季节,流感疫苗对预防因流感而住院的CAP无效。需要更有效的疫苗来预防最严重的流感。DOI: 10.18297/jri/vol2/iss1/6接收日期:2018年2月12日接收日期:2018年2月27日网站:https://ir.library.louisville.edu/jri隶属机构:1路易斯维尔大学传染病科,肯塔基州路易斯维尔40202 2路易斯维尔大学公共卫生与信息科学学院流行病学与人口健康系,肯塔基州路易斯维尔40202©2018,作者。*通讯作者:Thomas R Chandler工作地址:路易斯维尔大学传染病科工作邮箱:thomas.chandler@louisville.edu 26 ULJRI Vol 2, (1) 2018 ORIGINAL RESEARCH本研究的目的是确定流感疫苗预防流感-CAP患者住院的有效性,并确定在普通人群中估计的有效性在多大程度上估计了住院的CAP患者的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信